Bronchoalveolar Lavage Fluid Collection from a Mouse Model Infected with Non-typeable Haemophilus influenzae
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:17 min • October 30th, 2025
Loading...
Overview
This article describes a method for isolating immune cells from the bronchoalveolar lavage fluid (BALF) of a mouse model infected with non-typeable Haemophilus influenzae. The procedure involves several steps of fluid collection and cell separation to prepare samples for downstream analysis.
Key Study Components
Area of Science
- Immunology
- Microbiology
- Cell Biology
Background
- Non-typeable Haemophilus influenzae is a pathogenic bacterium.
- Understanding immune responses in the lungs is crucial for developing treatments.
- Bronchoalveolar lavage is a technique used to collect fluid from the lungs.
- Isolation of immune cells is essential for studying their role in infections.
Purpose of Study
- To demonstrate a protocol for collecting and isolating immune cells from BALF.
- To facilitate downstream analysis of immune responses in lung infections.
- To provide a method that can be replicated in similar studies.
Methods Used
- Use of a euthanized mouse model with an exposed trachea.
- Collection of BALF using a catheter and wash buffer.
- Centrifugation to separate cells from the lavage fluid.
- Resuspension of cells in lysis buffer for further analysis.
Main Results
- Successful recovery of immune cells from the BALF.
- Isolation of cells for downstream analysis.
- Demonstration of the effectiveness of the washing and lysis procedures.
- Preparation of samples for further immunological studies.
Conclusions
- The described method is effective for isolating immune cells from lung lavage fluid.
- This protocol can aid in understanding immune responses to lung infections.
- Future studies can utilize this method for various immunological investigations.
Frequently Asked Questions
What is bronchoalveolar lavage?
Bronchoalveolar lavage is a procedure used to collect fluid from the lungs for analysis.
Why is it important to isolate immune cells?
Isolating immune cells allows researchers to study their functions and responses in detail.
What type of mouse model is used in this study?
A euthanized mouse model infected with non-typeable Haemophilus influenzae is used.
What are the main components of the wash buffer?
The wash buffer contains an anticoagulant to prevent clotting and a sugar to preserve cell integrity.
How are the cells prepared for analysis?
Cells are centrifuged, resuspended in lysis buffer, and then prepared for downstream analysis.
Executive Industry Relevance
Bronchoalveolar lavage fluid (BALF) collection from mouse models infected with non-typeable Haemophilus influenzae enables direct interrogation of pulmonary immune responses in a controlled, disease-relevant system. This workflow supports mechanistic de-risking and target validation for respiratory infection research, providing quantitative cellular outputs for downstream immunological analysis. The approach is positioned at the interface of early discovery and translational research, informing portfolio decisions in respiratory and infectious disease pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct sampling of immune cell populations from infected lung tissue for mechanistic studies.
- Supports functional target validation by isolating cells involved in host-pathogen interactions.
- Provides a platform for hypothesis-driven interrogation of immune pathways in vivo.
Screening & Assay Development
- Generates validated biological samples for downstream cellular and molecular assays.
- Facilitates assay standardization by using pooled, reproducible BALF collections.
- Supports quantitative analysis of immune cell subsets and pathogen burden.
Translational & Preclinical Research
- Aligns with disease-relevant mouse models to bridge discovery and preclinical validation.
- Enables assessment of immune modulation and therapeutic intervention effects in vivo.
- Provides continuity for biomarker identification and translational research in respiratory disease.
Pipeline & Workflow Integration
This BALF collection protocol integrates into the early discovery-to-preclinical continuum for respiratory infection models.
- Discovery Biology: Supports hypothesis testing and mechanistic de-risking by enabling immune cell isolation from infected lungs.
- Screening: Delivers reproducible, quantitative samples for downstream immunological and microbiological assays.
- Analytics: Provides cellular and pathogen readouts to compare experimental conditions and interventions.
- Translational Research: Facilitates alignment with preclinical models for biomarker and efficacy studies.
- Enterprise Reuse: Establishes a standardized protocol adaptable across respiratory infection models and therapeutic programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune response characterization and target validation.
- Operational Value: Enhances reproducibility and standardization of sample collection and processing.
- Strategic Value: Informs go/no-go decisions by providing robust, quantitative immune cell data.
- Portfolio Impact: Supports risk-adjusted prioritization of respiratory and infectious disease assets.
Implementation Considerations
- Requires technical expertise in mouse handling and surgical procedures.
- Needs access to centrifugation and cell processing infrastructure.
- Demands cross-team standardization for sample pooling and buffer preparation.
- Adaptable to various mouse models and infection protocols with minor modifications.
- Limited to post-mortem analysis and not suitable for longitudinal sampling in the same animal.
Biopharma FAQs
Why does null hypothesis testing matter for BALF immune cell analysis?
Null hypothesis testing in BALF immune cell analysis ensures that observed differences in cell populations or pathogen burden are statistically significant and not due to random variation. This rigor is essential for target validation and mechanistic de-risking in respiratory infection models. Reliable statistical outputs support confident advancement decisions in discovery pipelines.
How does independent variable isolation fit BALF collection workflows?
Isolating independent variables, such as infection status or treatment, during BALF collection allows for controlled comparison of immune responses. This enables clear attribution of observed effects to specific interventions, supporting robust experimental design and downstream assay development. Such isolation is critical for reproducibility and mechanistic clarity in early discovery.
What do quantitative dependent variable measurements in BALF enable?
Quantitative measurements of immune cells and pathogens in BALF provide actionable data for evaluating intervention efficacy and immune modulation. These outputs enable teams to compare experimental groups, assess dose responses, and identify translational biomarkers. Quantitative readouts are foundational for data-driven decision-making in biopharma R&D.
Why are replication requirements important for BALF-based studies?
Replication in BALF-based studies ensures that findings are robust and reproducible across experiments and teams. Meeting replication standards facilitates cross-functional collaboration, supports assay transferability, and underpins confidence in preclinical data packages. Consistent replication is vital for advancing candidates through the discovery pipeline.
What statistical analysis capabilities are needed before BALF data implementation?
Statistical analysis capabilities such as group comparisons, variance assessment, and significance testing are required to interpret BALF-derived data. These analyses validate the reliability of immune cell and pathogen measurements, guiding go/no-go decisions and portfolio prioritization. Robust analytics are essential for translating BALF findings into actionable R&D insights.
10:55
Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance
Related Videos
0 Views
09:17
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Related Videos
0 Views
06:32
Assessing Respiratory Immune Responses to Haemophilus Influenzae
Related Videos
0 Views
02:51
Culturing Non-typeable Haemophilus influenzae
Related Videos
0 Views
03:17
A Mouse Model to Study the Pathogenic Transition of Streptococcus pneumoniae Following Viral Co-Infection
Related Videos
0 Views
03:03
Identification and Enumeration of Immune Cells in Bronchoalveolar Lavage Fluid by Flow Cytometry
Related Videos
0 Views
09:56
Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
Related Videos
0 Views
07:43
A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Related Videos
0 Views
07:03
Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
Related Videos
0 Views
10:44
Influenza A Virus Studies in a Mouse Model of Infection
Related Videos
0 Views
Last updated: 1 August 2026